Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer
Phase 1/2 Terminated
34 enrolled 15 charts
APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma
Phase 1/2 Terminated
21 enrolled
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
Phase 1/2 Terminated
9 enrolled 7 charts
Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase 1/2 Terminated
12 enrolled 8 charts
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma
Phase 1/2 Terminated
34 enrolled
Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca
Phase 1/2 Terminated
27 enrolled 12 charts
Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer
Phase 1/2 Terminated
7 enrolled 11 charts
PROPEL
Phase 1/2 Terminated
162 enrolled 21 charts
PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer
Phase 1/2 Terminated
34 enrolled
Abraxane and Alimta in Advanced Solid Tumors
Phase 1/2 Terminated
49 enrolled 10 charts
Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery
Phase 1/2 Terminated
5 enrolled 11 charts
Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC
Phase 1/2 Terminated
13 enrolled 15 charts